Clinical Study to Investigate the Pharmacokinetics, Safety and Tolerability Following Single Administration of CHF6001 in Subjects With Mild, Moderate and Severe Liver Impairment in Comparison With Matched Healthy Control Subjects
Clinical trial NCT05373953 · COMPLETED
Trial details
- NCT number
- NCT05373953
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-05
- Primary completion
- 2022-11-25
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.